Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hematology-Oncology

Reuters reports that Rockwell Medical‘s “late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease [CKD].” The study tested Soluble Ferric...
Reuters reports that Celgene Corp has met their goal in treatment of blood cancer patients with a drug called Revlimid. Revlimid has already been approved for “use in multiple myeloma patients who have failed at least one prior therapy, mantle cell...

Reuters Health • The Doctor's Channel Daily Newscast

Rituximab Safe for Cutaneous B-cell Lymphoma but Relapse Common

NEW YORK (Reuters Health) – A small study indicates that most patients with cutaneous B-cell lymphoma who respond well to rituximab relapse after about two years. On the positive side, the researchers found that rituximab treatment is not associated...